WallStSmart

Amrize Ltd (AMRZ)vsJames Hardie Industries PLC ADR (JHX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 127% more annual revenue ($12.26B vs $5.41B). AMRZ leads profitability with a 10.2% profit margin vs 2.7%. AMRZ appears more attractively valued with a PEG of 1.22. JHX earns a higher WallStSmart Score of 63/100 (C+).

AMRZ

Buy

62

out of 100

Grade: C+

Growth: 4.0Profit: 6.5Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

JHX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 5.5Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: 1.24

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
21.2%8/10

Strong operational efficiency at 21.2%

JHX3 strengths · Avg: 8.7/10
Revenue GrowthGrowth
63.9%10/10

Revenue surging 63.9% year-over-year

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

EPS GrowthGrowth
23.4%8/10

Earnings expanding 23.4% YoY

Areas to Watch

AMRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
2.2%4/10

2.2% revenue growth

EPS GrowthGrowth
4.1%4/10

4.1% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

JHX4 concerns · Avg: 2.8/10
Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

P/E RatioValuation
104.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.22 suggests the stock is reasonably priced for its growth.

Bull Case : JHX

The strongest argument for JHX centers on Revenue Growth, Price/Book, EPS Growth. Revenue growth of 63.9% demonstrates continued momentum. PEG of 1.24 suggests the stock is reasonably priced for its growth.

Bear Case : AMRZ

The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : JHX

The primary concerns for JHX are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 104.2x leaves little room for execution misses. Thin 2.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

AMRZ profiles as a value stock while JHX is a hypergrowth play — different risk/reward profiles.

JHX is growing revenue faster at 63.9% — sustainability is the question.

AMRZ generates stronger free cash flow (431M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JHX scores higher overall (63/100 vs 62/100) and 63.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

James Hardie Industries PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

James Hardie Industries plc manufactures and sells fiber cement, gypsum fiber and cement bonded construction products for interior and exterior building construction applications primarily in the United States, Australia, Europe, New Zealand, the Philippines and Canada. The company is headquartered in Dublin, Ireland.

Want to dig deeper into these stocks?